CDNA vs VRN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CDNA · CareDx$70.00 ▼ 2.67%
VRN · Veren (Delisted)$6.01 ▲ 0.00%
Head to head
| Metric | CDNA | VRN |
|---|---|---|
| Price | $70.00 | $6.01 |
| Change today | ▼ 2.67% | ▲ 0.00% |
| Market cap | $3.68B | $3.68B |
| Return, 3 months | +47.4% | – |
| Return, year to date | +271.5% | – |
| Return, 1 year | +307.5% | – |
| P/E (TTM) | 29.5 | 19.6 |
| P/B | 7.9 | 0.8 |
| P/E percentile vs own 5y | 99th | 92nd |
| Dividend yield | – | 5.32% |
| Revenue growth (YoY, latest qtr) | +39.3% | +12.2% |
| Net profit growth (YoY) | +1,051.8% | -84.6% |
| Gross margin | 71.0% | 56.4% |
| Operating margin | 0.8% | 24.4% |
| Net margin | 25.9% | 6.2% |
| Return on equity | 33.0% | 4.0% |
| Analyst target vs. price | +32.1% | – |
| Analyst buy share | 75% | – |
| RSI (14) | 44 | – |
| 30-day volatility | 82.9% | – |
| Max drawdown, 1 year | -23.6% | – |
| Trend read | Leaning bearish | – |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CDNA is the largest of the group by market value.
- VRN carries the lowest trailing P/E.
- CDNA is growing revenue fastest.
- CDNA keeps the most profit per dollar of sales.